Ownership
Private
Employees
~100
Stage
Commercial
Modalities
Medical devicesMolecular diagnostics

Cleveland Diagnostics General Information

Commercial stage company with IsoPSA blood test for prostate cancer detection that helps reduce unnecessary biopsies. The test analyzes protein structure rather than concentration for better diagnostic accuracy.

Contact Information

Website
Primary Industry
Diagnostics
Corporate Office

Drug Pipeline

IsoPSA
Commercial
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 2
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum
Drug Asset 3
Phase X
Indications: Lorem ipsum dolor sit
Modality: Lorem ipsum

For full access to Cleveland Diagnostics's pipeline data

Book a demo

Key Partnerships

Cleveland Clinic, Dow BioMedica

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Cleveland Diagnostics Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Cleveland Diagnostics's complete valuation and funding history, request access »

Cleveland Diagnostics Investors

Novo Holdings
Investor Type: Venture Capital
Holding: Minority
Symbiotic Capital
Investor Type: Venture Capital
Holding: Minority
Other undisclosed existing investors
Investor Type: Venture Capital
Holding: Minority